mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-08 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-08 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-07 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |